0001410428 false 0001410428 2022-06-08
2022-06-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC
20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(D) of the Securities Exchange Act
Of 1934
Date of report (Date of earliest event reported):
June 8, 2022
XpresSpa Group, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-34785 |
|
20-4988129 |
(Commission File Number) |
|
(IRS
Employer Identification No.) |
254 West 31st
Street,
11th Floor,
New York,
New York |
|
10001 |
(Address of Principal Executive
Offices) |
|
(Zip
Code) |
(212)
309-7549
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
¨ |
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
¨ |
Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
¨ |
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
¨ |
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
[ ]
Title of each
class |
|
Trading Symbol(s) |
|
Name of each exchange on which
registered |
Common Stock, par value $0.01 per share |
|
XSPA |
|
The Nasdaq Stock Market |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ¨
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On June 8, 2022, XpresSpa Group, Inc. (the “Company”) received a
written notification (the “Notice”) from the Listing Qualifications
Department of the NASDAQ Stock Market LLC (“Nasdaq”) notifying the
Company that the closing bid price for its common stock had been
below $1.00 for 30 consecutive business days and that the Company
therefore is not in compliance with the minimum bid price
requirement for continued inclusion on The Nasdaq Capital Market
under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”).
The Notice has no immediate effect on the listing or trading of the
Company’s common stock, which continues to trade on the Nasdaq
Capital Market under the symbol “XSPA”.
Under the Nasdaq Listing Rules, the Company has a period of 180
calendar days from the date of the Notice to regain compliance with
the Bid Price Requirement. Accordingly, the Company has until
December 5, 2022 (the “Compliance Date”), to regain compliance with
the Bid Price Requirement. To regain compliance, the closing bid
price of the Company’s common stock must be at least $1.00 for a
minimum of ten consecutive business days prior to the Compliance
Date. In the event the Company does not regain compliance by the
Compliance Date, the Company may be eligible for an additional 180
calendar day compliance period. To qualify for this second
compliance period, the Company will be required to meet the
continued listing requirement for market value of publicly held
shares and all other initial listing standards for The Nasdaq
Capital Market, with the exception of the Bid Price Requirement,
and will need to provide written notice of its intention to cure
the deficiency during the second compliance period, by effecting a
reverse stock split, if necessary.
The Company intends to monitor the closing bid price of its common
stock and may, if appropriate, consider available options to regain
compliance with the Bid Price Requirement. However, there can be no
assurance that the Company will be able to regain compliance with
the Bid Price Requirement, or will otherwise be in compliance with
other Nasdaq Listing Rules.
Item 5.02. |
Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers |
On June 14, 2022, the Company announced the separation of service
with the Company of James A. Berry, the Chief Financial Officer,
effective June 13, 2022. The Company also announced that the Board
had appointed Omar A. Haynes as Interim Chief Financial Officer of
the Company, which became effective on June 13, 2022. In such role,
Mr. Haynes will serve as the Company’s principal financial officer
and principal accounting officer for SEC reporting purposes,
pursuant to the terms of his current employment arrangements with
the Company.
Mr. Haynes, 40, has served as Vice President of Treasury &
Finance of the Company since June 2021 and will continue to retain
those titles while serving as the Company’s Interim Chief Financial
Officer. He joined the Company as Associate Director of
Finance in March 2017, then served as Director of Finance,
Analytics & Treasury from January 2019 to June 2020 and
Treasurer & Senior Director of Finance from June 2020 to May
2021. Before joining the Company, he worked in corporate
structuring and interim management consulting, focusing on
performance improvement and cash management.
For his service as Interim Chief Financial Officer, Mr. Haynes will
receive a base salary of $288,750 annually, subject to review by
the Compensation Committee of the Company’s board of directors. He
is eligible to receive an annual cash bonus with a target of 50% of
his base salary and will be eligible to participate in any annual
bonus or other incentive compensation program that the Company may
adopt from time to time for its executive officers.
There was no other arrangement or understanding pursuant to which
Mr. Haynes was selected as an officer of the Company. There are no
family relationships between Mr. Haynes and any director or
executive officer of the Company. There are no related party
transactions in respect of the Company of the kind described in
Item 404(a) of Regulation S-K in which Mr. Haynes was a
participant.
Item 8.01. Other Events
On June 14, 2022, the Company issued a press release regarding the
changes in roles of Messrs. Berry and Haynes discussed in Item 5.02
above. A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and
Exhibits
(d) Exhibits
99.1
Press Release, dated June 14, 2022
104 Cover page Interactive Data File
(embedded within the Inline XBRL document)
FORWARD-LOOKING STATEMENTS
This Form 8-K contains forward-looking statements that we intend to
be subject to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. All statements contained in this
Form 8-K, other than statements of historical facts may constitute
forward-looking statements within the meaning of the federal
securities laws. These statements can be identified by words such
as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,”
“believes,” “should,” “intends,” “estimates,” and other words of
similar meaning. Any forward-looking statements contained herein
are based on current expectations, and are subject to a number of
risks and uncertainties. Many factors could cause our actual
activities or results to differ materially from the activities,
performance, achievements or results to differ materially from the
activities and results anticipated in forward-looking statements.
These risks and uncertainties include those described in the “Risk
Factors” section as detailed from time to time in the Company’s
reports filed with the Securities and Exchange Commission (“SEC”),
including the Company’s annual report on Form 10-K, periodic
quarterly reports on Form 10-Q, current reports on Form 8-K and
other documents filed with the SEC. In addition, forward-looking
statements may also be adversely affected by general market
factors, general economic and business conditions, including
potential adverse effects of public health issues, such as the
COVID-19 outbreak (including any new variant strains of the
underlying virus) on economic activity, among other factors. The
forward-looking statements contained in this Form 8-K speak only as
of the date the statements were made, and the Company does not
undertake any obligation to update forward-looking statements,
except as required by law.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
XpresSpa Group,
Inc. |
|
|
|
Date: June 14, 2022 |
By: |
/s/ Scott R. Milford |
|
Name: |
Scott R.
Milford |
|
Title: |
Chief Executive
Officer |
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Sep 2023 to Oct 2023
XpresSpa (NASDAQ:XSPA)
Historical Stock Chart
From Oct 2022 to Oct 2023